RESOLUTION MEDICAL acquired by RESONETICS
Context
The acquisition of Resolution Medical by Resonetics signifies a major step in the group’s expansion toward a comprehensive, full-lifecycle service model. The strategic rationale for this transaction centers on an "integrated-platform" maneuver, merging the target’s technical operational depth in biosimulation and cleanroom assembly with the acquirer’s established scale in laser-based component manufacturing and battery systems. This structural alignment provides the organization with the scientific talent and technological hardware necessary to manage the increasing technical complexity of neuromodulation and structural heart devices.
RESOLUTION MEDICAL, which reported an EBITDA margin of in 2026, is valued in this transaction at an EV/EBITDA multiple of , a level to compare with the average currently observed in the Healthcare & Pharma sector (15.6x).
-> Deep-dive in Healthcare & Pharma market trends
Target
Resolution Medical is a technical innovation partner specializing in the design, development, and assembly of sophisticated interventional and neuromodulation devices. The organization operates as a high-fidelity gateway for medical technology OEMs, providing the scientific hardware and engineering talent required to transition innovative therapies from concept to New Product Introduction (NPI). Rather than focusing solely on component manufacturing, the firm utilizes advanced biosimulation and electronics-integrated assembly to validate device performance before commercial-scale execution. Its strategy involves reducing technical risk for partners by managing complex structural heart and neuromodulation sub-assemblies within specialized cleanroom environments.
Ent. Value
Equity Value
Multiples
EV / Revenue
EV / EBITDA
EV / EBIT
Historical Financials (EUR)
Similar deals in Life Sciences
| Date | Acquirer | Target | Country | Sector |
|---|---|---|---|---|
| 04/2026 | DEVYSER DIAGNOSTICS | CYBERGENE | SWEDEN | Diagnostic Equipment |
| 04/2026 | FOR TALENTS / UI INVESTISSEMENT / GENEO | NEFTYS PHARMA | FRANCE | Animal Health |
| 03/2026 | Abbott Laboratories | Exact Sciences | UNITED STATES | Diagnostic Equipment |
| 03/2026 | LONE STAR FUNDS | LONZA CHI | Switzerland | CDMO |
| 03/2026 | SIPAREX | WINNCARE | FRANCE | Medical Devices |
| 03/2026 | DEUTSCHE BETEILIGUNGS (DBAG) | HIPP TECHNOLOGY GROUP | GERMANY | Implants & Prosthetics |
| 02/2026 | VIVO CAPITAL | DUTSCHER | FRANCE | Medical Consumables |
| 02/2026 | NORD HOLDING | HALLMARQ VETERINARY IMAGING | UNITED KINGDOM | Diagnostic Equipment |
| 02/2026 | IMA GROUP | PROSYS | IRELAND | Medical Devices |
| 02/2026 | CIMG | DAREN TECHNOLOGY | CHINA | R&D Biotech |
REFERENCES
Note: This page provides detailed data on a private equity M&A transaction. Detailed and exact financial metrics for the acquisition of RESOLUTION MEDICAL by RESONETICS are reserved for mynth community members. Register for free to unlock full data.
Authors: This transaction was contributed by a verified mynth contributor and cross-checked against available transaction documents and official company communications.
Press release: view release
Target: resolution medical
Acquirer: resonetics